000 01660 a2200481 4500
005 20250515060828.0
264 0 _c20070613
008 200706s 0 0 eng d
022 _a0006-8993
024 7 _a10.1016/j.brainres.2007.01.131
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJakel, Rebekah J
245 0 0 _aNrf2-mediated protection against 6-hydroxydopamine.
_h[electronic resource]
260 _bBrain research
_cMay 2007
300 _a192-201 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAstrocytes
_xphysiology
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCell Transplantation
_xmethods
650 0 4 _aCells, Cultured
650 0 4 _aCerebral Cortex
_xcytology
650 0 4 _aDocosahexaenoic Acids
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEmbryo, Mammalian
650 0 4 _aFemale
650 0 4 _aGreen Fluorescent Proteins
_xmetabolism
650 0 4 _aHydroquinones
_xpharmacology
650 0 4 _aIn Situ Nick-End Labeling
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aNF-E2 Transcription Factor, p45 Subunit
_xdeficiency
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aNeurotoxins
_xtoxicity
650 0 4 _aOxidopamine
_xtoxicity
650 0 4 _aTransfection
650 0 4 _aTyrosine 3-Monooxygenase
_xmetabolism
700 1 _aTownsend, Jessica A
700 1 _aKraft, Andrew D
700 1 _aJohnson, Jeffrey A
773 0 _tBrain research
_gvol. 1144
_gp. 192-201
856 4 0 _uhttps://doi.org/10.1016/j.brainres.2007.01.131
_zAvailable from publisher's website
999 _c16893363
_d16893363